#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    SAPHO syndrome Anti-neutrophil cytoplasmic antibody positive vasculitis Anal fistula Soft tissue necrosis Endometrial cancer recurrent Primitive neuroectodermal tumour Haemophagocytic lymphohistiocytosis Epidermolysis bullosa Transferrin decreased Mantle cell lymphoma recurrent Neuropathic arthropathy Spina bifida Staphylococcal infection Waldenstrom's macroglobulinaemia refractory C3 glomerulopathy More trials…

    Learn about Rare Diseases

    Encephalitis autoimmune – Treatment Marginal zone lymphoma refractory – Life with Disease Gaucher’s disease type I Immunodeficiency congenital – Life with Disease Idiopathic pulmonary fibrosis – Diagnostics Glomerulonephritis membranoproliferative – Trials in Disease Waldenstrom’s macroglobulinaemia – Treatment Primary immunodeficiency syndrome – Treatment Sjogren’s syndrome – Basic Information Anaplastic thyroid cancer – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Aprepitant Nemolizumab VANADIUM OXIDE SULFATE Tamoxifen Citrate Pomalidomide Metformin GS-4321 Quizartinib Dihydrochloride Necvax-Neo1 Chloroprocaine Hydrochloride Azd5863 Microcrystalline Cellulose Ethinylestradiol Glucagon Azenosertib VMX-C001 Sulfonamides, Urea Derivatives CICLOPIROX Imipenem Monohydrate PALAZESTRANT More therapies…

    Learn about Your Condition

    Vascular dementia Intervertebral disc protrusion Lumbosacral radiculopathy Medullary thyroid cancer Colon cancer stage IV Immunosuppression Genitourinary tract neoplasm Plasmablastic lymphoma Oedema peripheral Deafness bilateral Sarcoidosis Diabetes insipidus Post cardiac arrest syndrome Meniere's disease Mucous membrane pemphigoid More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial Infections and Mycoses

  • Short-course (7‑day) versus standard 14‑day ciprofloxacin treatment for men with serious urinary tract infection

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Bacterial prostatitis
    • Pyelonephritis acute
    • Urinary tract infection
    Investigated Drugs:
    • Ciprofloxacin
    Belgium

  • Evaluating ceftazidime and avibactam with rapid testing for patients with bloodstream infections, hospital-acquired pneumonia, or ventilator-associated pneumonia

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Avibactam
    • Ceftazidime
    Italy

  • Comparing local gentamicin or vancomycin hydrochloride to a drug combination for patients with diabetic foot osteomyelitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Diabetic foot
    • Osteomyelitis
    Investigated Drugs:
    • Amoxicillin Trihydrate
    • Cefalexin Monohydrate
    • Clindamycin
    Finland

  • Study of the safety and effects of gepotidacin in children aged 2 to 12 years with bacterial infections such as urinary tract infections

    Not yet recruiting

    1 1 1
    Poland Spain

  • A study to evaluate the safety and effectiveness of dalbavancin in patients with erysipelas or limited cellulitis being treated at home.

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Dalbavancin
    Austria

  • Study of the distribution of cefazolin in the chest area of children undergoing heart surgery to prevent infection.

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Cefazolin
    France
Previous Page
1 … 22 23 24 25 26 … 46
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!